MannKind Corporation (MNKD) Deep Dive Video

Name: MannKind Corporation (MNKD) Deep Dive Video | Flash
Uploaded: 2026-01-14T09:15:25.977Z
Description: MannKind is a catalyst-heavy biotech transition story: Furoscix and pediatric Afrezza could unlock major upside, but Tyvaso DPI royalty risk and leverage keep the rebound high-stakes.

Summary

MannKind is a catalyst-heavy biotech transition story: Furoscix and pediatric Afrezza could unlock major upside, but Tyvaso DPI royalty risk and leverage keep the rebound high-stakes.

View MNKD stock page · Read the MNKD research report

Loading the video player…

Loading Flash…